This report contains market size and forecasts of Hospital-acquired Infection Diagnostics in Global, including the following market information:
- Global Hospital-acquired Infection Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hospital-acquired Infection Diagnostics market was valued at 4991.3 million in 2021 and is projected to reach US$ 7439.1 million by 2028, at a CAGR of 5.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Instrument and Reagents Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hospital-acquired Infection Diagnostics include Abbott Laboratories, Advan DX, Abbott, Astrazeneca PLC, Bayer Schering Pharma LLC, Becton Dickinson And Company, Cepheid Inc., Roche AG and Daiichi Sankyo and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hospital-acquired Infection Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hospital-acquired Infection Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hospital-acquired Infection Diagnostics Market Segment Percentages, by Type, 2021 (%)
- Instrument and Reagents
- Consumables
Global Hospital-acquired Infection Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hospital-acquired Infection Diagnostics Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Clinics
- Ambulatory Surgery Centers (ASC)
- Others
Global Hospital-acquired Infection Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hospital-acquired Infection Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Hospital-acquired Infection Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Hospital-acquired Infection Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Abbott Laboratories
- Advan DX
- Abbott
- Astrazeneca PLC
- Bayer Schering Pharma LLC
- Becton Dickinson And Company
- Cepheid Inc.
- Roche AG
- Daiichi Sankyo
- Hologic, Inc.
